News
ReNeuron's latest press releases
ReNeuron announces publication of pre-clinical data with its ReN003 programme for diseases of the retina . 10/08/09
Guildford, UK, 10 August 2009: ReNeuron Group plc (LSE: RENE.L) today announces the publication of two papers regarding pre-clinical data with its …
Read article2008/09 Annual Report and Accounts. 31/07/09
Guildford, UK, 31 July 2009: ReNeuron Group plc (LSE: RENE.L) gives notice that its Annual Report and Accounts for the year ended 31 March 2009 have …
ReNeuron receives UK ethics committee Favourable Opinion for stroke clinical trial. 30/07/09
Guildford, UK, 30 July 2009: ReNeuron Group plc (LSE: RENE.L) today announces that the UK Gene Therapy Advisory Committee (GTAC) has issued a …
ReNeuron welcomes launch of Office for Life Sciences "Life Sciences Blueprint" . 15/07/09
Guildford, UK, 14 July 2009: ReNeuron Group plc (LSE: RENE.L) welcomes today’s launch of the "Life Sciences Blueprint" document from the Office …
ReNeuron announces publication of data on mechanism of action of lead CTX stem cell line . 08/07/09
Guildford, UK, 8 July 2009: ReNeuron Group plc (LSE: RENE.L) today announces the publication in Stem Cells and Development 1 of pre-clinical data …
Preliminary Results for the Year Ended 31 March 2009 . 30/06/09
ReNeuron announces preliminary results for the Group for the year ended 31 March 2009.
ReNeuron signs manufacturing contract to provide stem cells for stroke clinical trial. 09/06/09
Guildford, UK, 9 June 2009: ReNeuron Group plc (LSE: RENE.L) today announces that it has signed a contract with Angel Biotechnology Holdings plc (&…
Final closing of the placing and capitalisation of loan notes. 18/05/09
Guildford, UK, 18 May 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page